Статья

Establishment of murine hybridoma cells producing antibodies against spike protein of sars‐cov‐2

N. Antipova, T. Larionova, A. Siniavin, M. Nikiforova, V. Gushchin, I. Babichenko, A. Volkov, M. Shakhparonov, M. Pavlyukov,
2021

In 2020 the world faced the pandemic of COVID‐19 severe acute respiratory syndrome caused by a new type of coronavirus named SARS‐CoV‐2. To stop the spread of the disease, it is crucial to create molecular tools allowing the investigation, diagnoses and treatment of COVID‐19. One of such tools are monoclonal antibodies (mAbs). In this study we describe the development of hybridoma cells that can produce mouse mAbs against receptor binding domain of SARS‐CoV‐2 spike (S) protein. These mAbs are able to specifically detect native and denatured S proteins in all tested applications, including immunoblotting, enzyme‐linked immunosorbent assay, immunofluorescence staining of cells and immunohistochemical staining of paraffin embedded patients’ tissue samples. In addition, we showed that the obtained mAbs can efficiently block SARS‐ CoV‐2 infection in in vitro experiments. Finally, we determined the amino acid sequence of light and heavy chains of the mAbs. This information will allow the use of corresponding peptides to establish genetically engineered therapeutic antibodies. To date multiple mAbs against SARS‐CoV‐ 2 proteins have been established, however, bigger sets of various antibodies will allow the detection and neutralization of SARS‐CoV‐2, even if the virus acquires novel mutations. © 2020, MDPI AG. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • N. Antipova
    Department of Functioning of Living Systems, Shemyakin‐Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russian Federation
  • T. Larionova
    Institute of Medicine, Рeoples’ Friendship University of Russia, RUDN University), Moscow, 17198, Russian Federation
  • A. Siniavin
    Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow, 101000, Russian Federation
  • M. Nikiforova
    N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russian Federation
  • V. Gushchin
    E.O. Mukhin Municipal Clinical Hospital, Moscow, 111399, Russian Federation
  • I. Babichenko
  • A. Volkov
  • M. Shakhparonov
  • M. Pavlyukov
Название журнала
  • International Journal of Molecular Sciences
Том
  • 21
Выпуск
  • 23
Страницы
  • 1-15
Ключевые слова
  • coronavirus spike glycoprotein; monoclonal antibody; recombinant protein; spike protein, SARS-CoV-2; virus antigen; amino acid sequence; animal; antigen antibody reaction; Bagg albino mouse; biosynthesis; chemistry; cytology; enzyme linked immunosorbent assay; genetics; HEK293 cell line; human; hybridoma; immunohistochemistry; immunology; isolation and purification; lung; metabolism; mouse; pathology; protein domain; virology; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Antigens, Viral; COVID-19; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; Humans; Hybridomas; Immunohistochemistry; Lung; Mice; Mice, Inbred BALB C; Protein Domains; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus
Издатель
  • MDPI AG
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus